Stay up to date with news and events
Huntington’s Disease Community Advocacy Helps Land Critical FDA Meeting for AMT-130
January 26, 2026
⏱️5 min read |The Huntington’s disease community’s unprecedented mobilization helped secure a high-priority FDA meeting to discuss the path forward for AMT-130.
Better Sleep, Better Function: New Study Links Sleep Quality to Clinical Outcomes in Huntington’s Disease
January 22, 2026
⏱️6 min read | Most people with HD report sleep problems, & new research suggests sleep quality is linked to many aspects of living with…
Keeping up with HD research just got easier: Introducing the HDBuzz Trial Tracker
January 20, 2026
⏱️6 min read | Ever wonder when to expect the next update from a clinical trial for Huntington’s disease? The HDBuzz Trial Tracker puts future…
Vaccines and Neurodegeneration: Lessons for Huntington’s Disease?
January 15, 2026
A recent article in the scientific journal, Nature describes “A natural experiment on the effect of herpes zoster (shingles) vaccination on dementia”. This study makes similar…
UniQure Secures Type A Meeting with FDA: What This Means for AMT-130
January 12, 2026
UniQure announced on January 9, 2026 that they have scheduled a Type A meeting with the FDA to discuss the approval pathway for AMT-130 in…